LEP and metabolic dysfunction-associated steatotic liver disease: For example, Dalbeni et al. (2022) recently found a positive correlation between the severity of MASLD/MASH and the levels of the hormone leptin, as well as an increase in platelet activation and aggregation, thereby potentially leading to the facilitation of arterial thrombosis [33].